Key points are not available for this paper at this time.
Design
Guideline
Answers are grounded in this paper and cite their sources.
Calls for urgent clinical prioritization of hypertension prevention; extends international consensus with updated global data.
Increased blood pressure (BP) is the second leading risk factor for death and disability globally according to the Global Burden of Disease Study.1 This work is an updated version of the World Hypertension League (WHL) 2014 Hypertension Fact sheet2 (www.whleague.org). Dr Mark Niebylski and Kimbree Redburn are paid WHL consultants but report no other conflicts. Dr Ji-Guang Wang reports receiving research grants and consulting fees from several BP-measuring device companies including A&D, AVITA, Honsun, Omron, and Rossmax but reports no other conflicts. Dr Michael Weber is a consultant for and received travel support from Omron but reports no other conflicts. All other primary authors including those from WHL and the International Society of Hypertension report no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: